EXPLORING THE STREPTOZOTOCIN-NICOTINAMIDE MOUSE MODEL IN BALB/C MICE: GAINING INSIGHTS INTO DIABETIC PNEUMOPATHY
DOI:
https://doi.org/10.69656/pjp.v20i3.1673Keywords:
Type 2 diabetes, Streptozotocin, NicotinamideAbstract
Background: Diabetic pneumopathy has been a topic of interest in the present era, and it caught the eye during the COVID-19 pandemic. Extensive research provides compelling data supporting the association between diabetes and lung injury, establishing the lung as a principal organ affected by diabetes. However, the understanding of diabetic lung has always remained under shadow. For this purpose, we aimed to search for diabetic lung conditions by using a type 2 diabetic model in BALB/c mice. Methods: The study spanned from May to June 2023 at Ziauddin University. Nicotinamide, followed by streptozotocin, was injected into the mice. Mice were confirmed diabetic on the 7th day and housed for the onset of diabetic lung complications. After 28 days, mice underwent an oral glucose tolerance test and were then sacrificed, followed by the collection of bronchoalveolar lavage fluid and the extraction of the lungs. Lungs were fixed for histological analysis. Results: The presence of increased glycaemic levels, further verified by abnormal glucose tolerance, confirmed the establishment of the type 2 diabetic model. Additionally, the diabetic group showed lung fibrotic changes. Conclusion: The foundation of a type 2 diabetic model with the target of generating pneumopathy was accomplished successfully.
Pak J Physiol 2024;20(3):31?6, DOI: https://doi.org/10.69656/pjp.v20i3.1673
Downloads
References
Tomic D, Shaw JE, Magliano DJ. The burden and risks of emerging complications of diabetes mellitus. Nat Rev Endocrinol 2022;18(9):525–39.
Schuyler MR, Niewoehner DE, Inkley SR, Kohn R. Abnormal lung elasticity in juvenile diabetes mellitus. Am Rev Respir Dis 1976;113(1):37–41.
Mameli C, Ghezzi M, Mari A, Cammi G, Macedoni M, Redaelli FC, et al. The diabetic lung: Insights into pulmonary changes in children and adolescents with type 1 diabetes. Metabolites 2021;11(2):69.
Al-Khlaiwi T, Alsabih AO, Khan A, Habib SH, Sultan M, Habib SS. Reduced pulmonary functions and respiratory muscle strength in Type 2 diabetes mellitus and its association with glycemic control. Eur Rev Med Pharmacol Sci 2021;25(23):7363–8.
Adeoti AO, Raimi TH, Fadare JO, Ibidapo R. Spirometric Indices in Type 2 Diabetes Mellitus Patients in a Nigerian Tertiary Institution. Eur J Med Health Sci 2021;3(3):10–4.
Choi HS, Lee SW, Kim JT, Lee HK. The association between pulmonary functions and incident diabetes: Longitudinal analysis from the ansung cohort in Korea. Diabetes Metab J 2020;44(5):699–710.
Rambaran K, Bhagan B, Ali A, Ali F, Toolsie S, Lobin R, et al. High prevalence of diabetes mellitus in a cohort of patients with chronic obstructive pulmonary disease in Trinidad, West Indies. Turk Thorac J 2019;20(1):12–7.
Rajasurya V, Gunasekaran K, Surani S. Interstitial lung disease and diabetes. World J Diabetes 2020;11(8):351–7.
Pugliese G, Vitale M, Resi V, Orsi E. Is diabetes mellitus a risk factor for CoronaVirus Disease 19 (COVID-19)? Acta Diabetol 2020;57(11):1275–85.
Kolahian S, Leiss V, Nürnberg B. Diabetic lung disease: fact or fiction? Rev Endocr Metab Disord 2019;20(3):303–19.
Rais N, Ved A, Ahmad R, Parveen K, Gautam GK, Bari DG, et al. Model of streptozotocin-nicotinamide induced type 2 diabetes: a comparative review. Curr Diabetes Rev 2022;18(8):58–69.
Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 1988;41(4):467–70.
Landini G, Martinelli G, Piccinini F. Colour deconvolution: Stain unmixing in histological imaging. Bioinformatics 2021;37(10):1485–7.
Wang D, Ma Y, Tong X, Zhang Y, Fan H. Diabetes mellitus contributes to idiopathic pulmonary fibrosis: A review from clinical appearance to possible pathogenesis. Front Public Health 2020;8:196.
Kopf S, Kumar V, Kender Z, Han Z, Fleming T, Herzig S, et al. diabetic pneumopathy —a new diabetes-associated complication: mechanisms, consequences and treatment considerations. Front Endocrinol (Lausanne) 2021;12:765201.
Birgani GA, Ahangarpour A, Khorsandi L, Moghaddam HF. Anti-diabetic effect of betulinic acid on streptozotocin-nicotinamide induced diabetic male mouse model. Braz J Pharm Sci 2018;54(2):e17171.
Jeon HY, Lee AJ, Kim EB, Kim M, Park WS, Ha KS. C-peptide attenuates hyperglycemia-induced pulmonary fibrosis by inhibiting transglutaminase 2. J Mol Endocrinol 2022;68(4):209–23.
Wang LM, Zhong NZ, Liu SJ, Zhu XY, Liu YJ. Hypoxia-induced acute lung injury is aggravated in Streptozotocin diabetic mice. Exp Lung Res 2015;41(3):146–54.
Yang J, Tan Y, Zhao F, Ma Z, Wang Y, Zheng S, et al. Angiotensin ii plays a critical role in diabetic pulmonary fibrosis most likely via activation of NADPH oxidase-mediated nitrosative damage. Am J Physiol Endocrinol Metab 2011;301(1):E132–44.
Liu XY, Wei DG, Li RS. Ghrelin attenuates inflammation in diabetic lung disease by TLR4 pathway in vivo and in vitro. BMJ Open Diabetes Res Care 2023;11(2):e003027.
Onk D, Onk OA, Erol HS, Özkaraca M, Çomakl? S, Ayazo?lu TA, et al. Effect of melatonin on antioxidant capacity, ?nflammation and apoptotic cell death in lung tissue of diabetic rats. Acta Cir Bras 2018;33(4):375–85.
Elewa YHA, Ichii O, Nakamura T, Kon Y. Pathological alternations of mediastinal fat-associated lymphoid cluster and lung in a streptozotocin-induced diabetic mouse model. Microsc Microanal 2021;27(1):187–200.
Kumar V, Agrawal R, Pandey A, Kopf S, Hoeffgen M, Kaymak S, et al. Compromised DNA repair is responsible for diabetes?associated fibrosis. EMBO J 2020;39(11):103477.
Bolat D, Ülger M, Baran M, Turan It, Yay A. Lung injury aggravated in Streptozotocin-induced diabetes: an experimental study. Cukurova Med J 2022;47(1):175–82.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Pakistan Journal of Physiology, Pak J Physiol, PJP is FREE for research and academic purposes. It can be freely downloaded and stored, printed, presented, projected, cited and quoted with full reference of, and acknowledgement to the author(s) and the PJP. The contents are published with an international CC-BY-ND-4.0 License.
